2014

China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results - Same Store Sales Increase 8.9% -

SHENZHEN, China, May 25, 2011 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended March 31, 2011.

Financial Highlights

For the quarter ended March 31, 2011:

  • Revenue increased by 9.0% to RMB618.1 million (US$94.4 million), compared to revenue of RMB567.2 million in first quarter 2010
  • Same store sales increased by 8.9% over the prior year's period
  • Income from operations was RMB11.8 million (US$1.8 million) compared to a loss of RMB4.2 million in first quarter 2010
  • Net income was RMB10.6 million (US$1.6 million) compared to RMB2.6 million for the same period of 2010

Mr. Jason Wu, Chief Executive Officer of Nepstar, commented, "We are pleased to share the positive progress of our strategic transition to a neighborhood store for one-stop pharmacy and convenience shopping. New merchandise in our convenience products category has contributed to the increase of sales by 8.9% on a same store basis, despite ongoing government pricing controls over some of our core pharmaceutical products.

"Household consumables continued to deliver growth in sales, which underscores our theme of bringing health and value to our customers' daily life.  We believe there is further growth potential in the convenience and household consumables market, where we may leverage our large store network and logistics coverage to our advantage.

"Our plan is to continue to introduce high-quality household consumables at competitive prices with the goal of increasing the average spending per customer per visit and to further drive same store productivity."

First Quarter Results

During the first quarter of 2011, the Company opened 25 new stores and closed 39 stores.  As of March 31, 2011, Nepstar had a total of 2,533 stores in operation.

Revenue for the quarter ended March 31, 2011 increased 9.0% to RMB618.1 million (US$94.4 million), compared to revenue of RMB567.2 million for the same period in 2010. Increased sales of newly introduced convenience products continued to offset the negative impact on drug sales from ongoing healthcare reform that has led to price cuts and diversion of patients from drugstores.

First quarter revenue contribution from prescription drugs was 19.6%, OTC drugs was 37.7%, nutritional supplements was 17.9%, traditional Chinese herbal products was 4.0% and convenience and other products was 20.8%. During the first quarter, the Company introduced 37 new SKUs (Stock Keeping Units) within the convenience products category. Sales of convenience products accounted for approximately 12.5% of total revenue for the first quarter.

Same store sales (for 2,275 stores opened before December 31, 2009) for the first quarter of 2011 increased by 8.9% compared to the same period in 2010. This growth was mainly attributable to increased sales of household consumables and other new non-pharmaceutical products introduced in the second half of 2010.

Nepstar's portfolio of private label products included 1,788 products as of March 31, 2011. Sales of private label products represented approximately 29.8% of revenue and 41.4% of gross profit for the first quarter of 2011.

First quarter gross profit was RMB294.8 million (US$45.0 million), compared to RMB272.2 million in the same period of 2010. Gross profit margin in the first quarter of 2011 was 47.7%, compared to 48.0% in the same period of 2010. The change in gross profit margin was mainly due to changes in revenue mix as the Company has introduced more household consumables with a lower gross profit margin compared to pharmaceuticals. The Company continued to make efforts to provide good-value private label products in convenience products category. In the first quarter, private label products' contribution to the convenience products category also reached 30.2%, helping maintain a reasonably favorable gross profit margin level on sales of convenience products.

Sales, marketing and other operating expenses as a percentage of revenue in the first quarter of 2011 decreased to 40.7% compared to 42.9% in the same period of 2010. This decrease from the same period of last year was primarily due to higher sales revenue generated from the diversification strategy and rigorous cost control measures.

General and administrative expenses as a percentage of revenue in the first quarter of 2011 were 5.1%, compared to 5.8% in the same period of 2010. The decrease was also due to cost control efforts and a higher revenue base in 2011.

As a result of the factors discussed above, income from operations in the first quarter of 2011 was RMB11.8 million (US$1.8 million), compared to a loss of RMB4.2 million in the same period of 2010. Operating margin was 1.9% in the first quarter of 2011.

Interest income for the first quarter of 2011 was RMB4.9 million (US$0.7 million), compared to RMB8.2 million in the same period of 2010. The decrease in interest income was mainly due to lower cash balances as a result of the dividend payments in 2010 and 2011, and share buyback program in 2010. Dividend income from cost method investments was RMB2.0 million (US$0.3 million), compared to that of RMB3.0 million in the same quarter of 2010. Equity income of an equity method investee was RMB1.0 million (US$0.2 million), compared to that of RMB1.8 million in the same quarter of 2010.

Nepstar's effective tax rate was 46.1% for the first quarter of 2011, compared to 66.8% for the same period in 2010. The decrease in effective tax rate was primarily because less valuation allowance was made for the deferred tax assets of loss-making subsidiaries due to their improved profitability in the first quarter of 2011.

Net income in the first quarter of 2011 was RMB10.6 million (US$1.6 million), which represented RMB0.10 (US$0.02) basic and diluted earnings per American depositary share ("ADS"). This compares to net income of RMB2.6 million, which represented RMB0.02 basic and diluted earnings per ADS in the same period of 2010. The total number of outstanding ordinary shares of the Company as of March 31, 2011 was 207.8 million. The weighted average number of ordinary shares in the first quarter of 2011 was 207.8 million. Each ADS represents two ordinary shares of the Company.

As of March 31, 2011, Nepstar's total cash, cash equivalents and bank deposits were RMB983.7 million (US$150.2 million) and its shareholders' equity was RMB1,375.5 million (US$210.0 million).

In the first quarter of 2011, net cash flow from operations was RMB1.0 million (US$0.2 million).

On January 18, 2011, Nepstar announced a special cash dividend of US$0.30 per ADS, which represents a total value to shareholders of approximately US$31 million. The distribution of the special dividend was partly paid around February 28, 2011 to shareholders of record as of the close of business on January 31, 2011.

In April 2011, Nepstar's Board approved the transfer of 100% ownership of Shenzhen Nepstar Industrial Co., Ltd. ("Nepstar Industrial"), a subsidiary company, to Neptunus Group, a related party. Nepstar Industrial has a registered capital of RMB100 million and paid-in capital of RMB20 million as of March 31, 2011. The net asset of Nepstar Industrial as of March 31, 2011 was RMB20 million. Neptunus Group will pay Nepstar RMB20 million in cash, to acquire Nepstar Industrial. Nepstar has not conducted any operations under Nepstar Industrial since its establishment in 2009. The purpose of the transaction is to simplify corporate structure and the divestment is not expected to influence Nepstar's financial position or business.

Business Outlook

"We expect that Chinese healthcare sector reform will be prolonged, as government policy initiatives take time to be thoroughly implemented," stated Mr. Wu.  "While the overall drugstore sector continues to experience revenue erosion and smaller chains and generic drug makers struggle, our shift to a hybrid model of pharmacy and convenience enables us to broaden our revenue stream and compensate for lost drug sales.  Moreover, the growth in sales of our household consumables enhances our chance of private labeling in this product category. We believe Nepstar is on its way to providing for even more consumers' healthcare and quality life needs. However, it may take some time to see an impact on our bottom line from the introduction of new products. We are still developing our product mix strategy, as we continue to assess the contribution of new product categories to our sales revenue and profitability."

Conference Call Information

The Company will host a conference call, to be simultaneously Web cast, on Wednesday, May 25, 2011 at 8:00 a.m. Eastern Time / 8:00 p.m. Beijing Time. Interested parties may participate in the conference call by dialing +1-877-407-9210 (North America) or +1-201-689-8049 (International) approximately five to ten minutes before the call start time. A live Web cast of the conference call will be available on the Nepstar Web site at http://www.nepstar.cn.

A replay of the call will be available shortly after the conclusion of the conference call through June 1, 2011 at 11:59 p.m. Eastern Time or June 2, 2011 at 11:59 a.m. Beijing Time. An archived Web cast of the conference call will be available on the Nepstar website at http://www.nepstar.cn. Interested parties may access the replay by dialing +1-877-660-6853 (North America) or +1-201-678-7415 (International) and entering account number 286 and conference ID number 372372.

About China Nepstar Chain Drugstore Ltd.

China Nepstar Chain Drugstore Ltd. (NYSE: NPD) is China's largest retail drugstore chain based on the number of directly operated stores. As of March 31, 2011, the Company had 2,533 stores across 74 cities, one headquarter distribution center and 14 regional distribution centers in China. Nepstar uses directly operated stores, centralized procurement and a network of distribution centers to provide its customers with high-quality, professional and convenient pharmacy services and a wide variety of other merchandise, including OTC drugs, nutritional supplements, herbal products, personal care products, family care products, and convenience products including consumables. Nepstar's strategy of centralized procurement, competitive pricing, customer loyalty programs and private label offerings has enabled it to capitalize on the robust economic growth in China and to take advantage of the demographic trend in China to achieve a strong brand and leading market position. For further information, please go to http://www.nepstar.cn

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release and the Company's strategic operational plans and business outlook, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

Exchange Rate Information

The United States dollar (US$) amounts disclosed in this press release are presented solely for the convenience of the reader. Translations of amounts from RMB into United States dollars for the convenience of the reader were calculated at the certified exchange rate of  US$1.00 = RMB6.5483 on March 31, 2011 as set forth in the H.10 weekly statistical release of the Federal Reserve Board.  No representation is made that the RMB amounts could have been, or could be, converted into US$ at that rate on March 31, 2011, or at any other date. The percentages stated are calculated based on RMB amounts.

Contacts


Lucia Qian

China Nepstar Chain Drugstore Ltd.

Vice President, IR

Phone: +86-755-2641-4065

Email: qianrt@nepstar.cn


Dixon Chen

Grayling

Investor Relations

Tel: +1-646-284-9403

Email: dixon.chen@grayling.com


Ivette Almeida

Grayling

Media Relations

Tel: +1-646-284-9455

Email: ivette.almeida@grayling.com



Tables follow


China Nepstar Chain Drugstore Ltd.

Unaudited Condensed Consolidated Statements of Operations

(amounts in thousands – except per-share data)



Three-month period ended


March 31


2010

2011

2011


RMB

RMB

USD


567,217

618,102

94,391

Revenue


(295,049)

(323,255)

(49,365)

Cost of goods sold


272,168

294,847

45,026

Gross profit


(243,378)

(251,785)

(38,450)

Sales, marketing and other operating expenses


(32,948)

(31,258)

(4,773)

General and administrative expenses


(4,158)

11,804

1,803

(Losses) / income from operations






8,226

4,868

743

Interest income

Interest expenses

(1,200)

-

-


2,997

2,000

305

Dividend income from cost method investments


1,846

1,020

156

Equity in income of an equity method investee

Income before income tax expense

7,711

19,692

3,007






(5,153)

(9,070)

(1,385)

Income tax expense

Net income attributable to China Nepstar Chain Drugstore Ltd.  

2,558

10,622

1,622






Basic earnings per ordinary share

0.01

0.05

0.01

Basic earnings per ADS

0.02

0.10

0.02

Diluted earnings per ordinary share

0.01

0.05

0.01

Diluted earnings per ADS

0.02

0.10

0.02





China Nepstar Chain Drugstore Ltd.

Unaudited Condensed Consolidated Balance Sheets

(amounts in thousands)



As of

As of

December 31,

March 31,


2010

2011

2011


RMB

RMB

USD

ASSETS




Current assets





1,139,796

983,680

150,219

Cash, cash equivalents and bank deposits


5,000

-

-

Restricted Cash


Accounts receivable, net of allowance for doubtful accounts

83,722

97,568

14,900


12,358

2,496

381

Amounts due from related parties


127,750

125,008

19,090

Prepaid expenses, deposits and other current assets


433,265

415,271

63,417

Inventories


3,551

2,403

367

Deferred tax assets


1,805,442

1,626,426

248,374

Total current assets





Non-current assets









192,019

181,340

27,693

Property and equipment, net


41,811

41,308

6,308

Rental deposits


12,638

12,638

1,930

Cost method investments


35,151

36,170

5,524

Equity method investment










8,227

-

-

Land use right


2,919

3,264

498

Intangible assets, net


51,089

51,819

7,913

Goodwill


1,813

1,722

263

Deferred tax assets


2,000

1,000

153

Deposits for acquisitions


347,667

329,261

50,282

Total non-current assets






2,153,109

1,955,687

298,656

Total assets





LIABILITIES AND SHAREHOLDERS' EQUITY




Current liabilities









313,773

309,979

47,338

Accounts payable


24,461

20,673

3,157

Amounts due to related parties


131,330

102,890

15,713

Accrued expenses and other payables


52,520

55,191

8,428

Income tax payable


26,102

18,788

2,869

Deferred income


-

42,553

6,498

Dividend payable





Total current liabilities

548,186

550,074

84,003





Non-current liabilities





18,794

19,308

2,948

Deferred income






16,922

10,842

1,656

Deferred tax liabilities


35,716

30,150

4,604

Total non-current liabilities





Total liabilities

583,902

580,224

88,607





Shareholders' equity





164

164

25

Share capital


1,501,809

1,297,250

198,105

Additional paid-in capital


(41,563)

(41,370)

(6,318)

Accumulated other comprehensive loss


108,797

119,419

18,237

Retained earnings


Total shareholders' equity

1,569,207

1,375,463

210,049






2,153,109

1,955,687

298,656

Total liabilities and shareholders' equity




SOURCE China Nepstar Chain Drugstore Ltd.



RELATED LINKS
http://www.nepstar.cn

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.